Clinical Trials Browser

Interventional × Histiocytic Neoplasms × ulixertinib × Clear all

NCT06411821 2025-12-15

Ulixertinib in People With Histiocytic Neoplasms

Phase 2 Recruiting

Histiocytic Neoplasms